These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16014392)

  • 61. Complementary and alternative medicine use in Australia: a national population-based survey.
    Xue CC; Zhang AL; Lin V; Da Costa C; Story DF
    J Altern Complement Med; 2007; 13(6):643-50. PubMed ID: 17718647
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Understanding support for complementary and alternative medicine in general populations: use and perceived efficacy.
    Stoneman P; Sturgis P; Allum N
    Health (London); 2013 Sep; 17(5):512-29. PubMed ID: 23239765
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Complementary and alternative medicine and coping in neuroimmunological diseases.
    Apel A; Greim B; Zettl UK
    J Neurol; 2007 May; 254 Suppl 2():II112-5. PubMed ID: 17503118
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cancer patients' experiences of using complementary therapies: polarization and integration.
    Smithson J; Paterson C; Britten N; Evans M; Lewith G
    J Health Serv Res Policy; 2010 Apr; 15 Suppl 2():54-61. PubMed ID: 20194431
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An exploratory qualitative study to investigate how patients evaluate complementary and conventional medicine.
    Lewith GT; Chan J
    Complement Ther Med; 2002 Jun; 10(2):69-77. PubMed ID: 12481954
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Patient Journeys of Nonintegration in Hungary: A Qualitative Study of Possible Reasons for Considering Medical Modalities as Mutually Exclusive.
    Zörgő S; Olivas Hernández OL
    Integr Cancer Ther; 2018 Dec; 17(4):1270-1284. PubMed ID: 30256678
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The experience of using complementary therapies after a diagnosis of cancer: a qualitative synthesis.
    Smithson J; Britten N; Paterson C; Lewith G; Evans M
    Health (London); 2012 Jan; 16(1):19-39. PubMed ID: 21177711
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Provider's Body in the Therapeutic Relationship: How Complementary and Alternative Medicine Providers Describe Their Work as Healers.
    Agarwal V
    Health Commun; 2019 Oct; 34(11):1350-1358. PubMed ID: 29924639
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Unanticipated benefits of CAM therapies for back pain: an exploration of patient experiences.
    Hsu C; Bluespruce J; Sherman K; Cherkin D
    J Altern Complement Med; 2010 Feb; 16(2):157-63. PubMed ID: 20180688
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Therapeutic pluralism and the politics of disclosure: breast cancer patients' experiences in public healthcare.
    Githaiga JN; Swartz L
    Afr Health Sci; 2022 Dec; 22(4):77-86. PubMed ID: 37092091
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Conventional or complementary medicine: what criteria for choosing do patients use?].
    Schär A; Messerli-Rohrbach V; Schubarth P
    Schweiz Med Wochenschr Suppl; 1994; 62():18-27. PubMed ID: 8073236
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A qualitative study of culturally embedded factors in complementary and alternative medicine use.
    Zörgő S; Purebl G; Zana Á
    BMC Complement Altern Med; 2018 Jan; 18(1):25. PubMed ID: 29357855
    [TBL] [Abstract][Full Text] [Related]  

  • 73. What patients expect from complementary therapy: a qualitative study.
    Richardson J
    Am J Public Health; 2004 Jun; 94(6):1049-53. PubMed ID: 15249314
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluating health-care: the perspectives of sufferers with upper limb pain.
    Calnan M; Wainwright D; O'Neill C; Winterbottom A; Watkins C
    Health Expect; 2005 Jun; 8(2):149-60. PubMed ID: 15860055
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Contribution of Anthroposophic Medicine to Self-Management: An Exploration of Concepts, Evidence, and Patient Perspectives.
    Baars EW; Koster EB; Verhoef J
    Complement Med Res; 2017; 24(4):225-231. PubMed ID: 28803238
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An interpretative phenomenological analysis of the embodiment of artificial limbs.
    Murray CD
    Disabil Rehabil; 2004 Aug; 26(16):963-73. PubMed ID: 15371044
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Complementary and alternative medicine use by lung cancer patients].
    Rossanaly Vasram R; Zysman M; Ribeiro Baptista B; Ederle C; Nguyen-Thi PL; Clement-Duchene C; Martinet Y
    Rev Pneumol Clin; 2017 Sep; 73(4):172-179. PubMed ID: 28756003
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Should NICE evaluate complementary and alternative medicine?
    Franck L; Chantler C; Dixon M
    BMJ; 2007 Mar; 334(7592):506. PubMed ID: 17347233
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Decay, Transformation, and Growth: Meaning-Making Processes of Patients With Acute Leukemia Within the First Year After Diagnosis or Relapse.
    Papadopoulou C; Johnston B; Themessl-Huber M
    Oncol Nurs Forum; 2016 Mar; 43(2):E73-81. PubMed ID: 26906141
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Should NICE evaluate complementary and alternative medicines?
    Colquhoun D
    BMJ; 2007 Mar; 334(7592):507. PubMed ID: 17347234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.